Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
Nautilus Biotechnology (NASDAQ: NAUT), a pioneer in single-molecule protein analysis platform development, has announced its participation in the upcoming Goldman Sachs 46th Annual Global Healthcare Conference. The company's management will engage in a fireside chat on June 10, 2025, at 2:00 p.m. Eastern Time. Investors and interested parties can access both live and archived webcasts of the presentation through the "Investors" section on Nautilus' website at www.nautilus.bio.
Nautilus Biotechnology (NASDAQ: NAUT), pioniere nello sviluppo di piattaforme per l'analisi delle proteine a singola molecola, ha annunciato la sua partecipazione alla prossima 46ª Conferenza Globale Annuale sulla Sanità di Goldman Sachs. Il management dell'azienda parteciperà a una chiacchierata informale il 10 giugno 2025, alle 14:00 ora orientale. Investitori e interessati potranno seguire la presentazione in diretta o in differita tramite webcast disponibile nella sezione "Investitori" del sito web di Nautilus all'indirizzo www.nautilus.bio.
Nautilus Biotechnology (NASDAQ: NAUT), pionero en el desarrollo de plataformas para el análisis de proteínas a nivel de molécula única, ha anunciado su participación en la próxima 46ª Conferencia Global Anual de Salud de Goldman Sachs. La dirección de la empresa participará en una charla informal el 10 de junio de 2025, a las 2:00 p.m., hora del Este. Inversores y personas interesadas podrán acceder a las transmisiones en vivo y archivos de la presentación a través de la sección "Inversores" en la página web de Nautilus, www.nautilus.bio.
Nautilus Biotechnology (NASDAQ: NAUT)는 단일 분자 단백질 분석 플랫폼 개발의 선구자로서, 다가오는 골드만 삭스 제46회 연례 글로벌 헬스케어 컨퍼런스에 참가할 예정임을 발표했습니다. 회사 경영진은 2025년 6월 10일 오후 2시(동부 표준시)에 진행되는 소규모 대화에 참여할 예정입니다. 투자자 및 관심 있는 분들은 Nautilus 웹사이트(www.nautilus.bio)의 "투자자" 섹션을 통해 생중계 및 녹화된 웹캐스트를 시청할 수 있습니다.
Nautilus Biotechnology (NASDAQ : NAUT), pionnier dans le développement de plateformes d'analyse des protéines au niveau moléculaire unique, a annoncé sa participation à la prochaine 46e conférence annuelle mondiale sur la santé de Goldman Sachs. La direction de l'entreprise participera à une discussion informelle le 10 juin 2025 à 14h00 heure de l'Est. Les investisseurs et les personnes intéressées pourront accéder aux webcasts en direct et en différé de la présentation via la section "Investisseurs" du site web de Nautilus à l'adresse www.nautilus.bio.
Nautilus Biotechnology (NASDAQ: NAUT), ein Pionier in der Entwicklung von Plattformen zur Einzelmolekül-Protein-Analyse, hat seine Teilnahme an der kommenden 46. jährlichen globalen Gesundheitskonferenz von Goldman Sachs angekündigt. Das Management des Unternehmens wird am 10. Juni 2025 um 14:00 Uhr Eastern Time an einem Fireside-Chat teilnehmen. Investoren und Interessierte können sowohl Live- als auch aufgezeichnete Webcasts der Präsentation über den Bereich "Investoren" auf der Nautilus-Website www.nautilus.bio abrufen.
- None.
- None.
SEATTLE, May 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating in the Goldman Sachs 46th Annual Global Healthcare Conference.
Nautilus’ management is scheduled to participate in a fireside chat on Tuesday, June 10, 2025, at 2:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.nautilus.bio.
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.
Media Contact
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
FAQ
When is Nautilus Biotechnology (NAUT) presenting at the Goldman Sachs Healthcare Conference 2025?
How can I watch Nautilus Biotechnology's (NAUT) presentation at the Goldman Sachs Conference?
What type of presentation will Nautilus Biotechnology (NAUT) give at the Goldman Sachs Conference?
What is Nautilus Biotechnology's (NAUT) main business focus?
